Medical News

RSS

COVID-19 lockdown restrictions impacted hospital admission rates throughout U.K.

Researchers quantify the impact that COVID-19 lockdowns had on healthcare services throughout the United Kingdom

31 May 2022

Unsweetened and sugar-sweetened coffee drinkers may have lower risk of death

A cohort study has found that compared to non-coffee drinkers, adults who drank moderate amounts (1.5 to 3.5 cups per day) of unsweetened coffee or coffee sweetened with sugar were less likely to die during a 7-year follow up period.

31 May 2022

New compounds for cancer immunotherapy via STING-mediated immune activation

Innovations in cancer immunotherapy have achieved clinical success by considerably increasing the survival rate of patients undergoing cancer treatment.

31 May 2022

Vitamin D therapy may be a useful addition to the treatment of ovarian cancer, study suggests

Ovarian cancer has one of the highest death rates of all cancers. One reason for this is that cancer turns the body's defenses against itself. However, new research from Nagoya University published in Matrix Biology suggests that vitamin D can effectively prevent one of the key pathways used by this cancer.

30 May 2022

Study reveals COVID-19's collateral damage on global cardiovascular services

A major study has revealed the "global collateral damage" caused by the disruption to cardiac services from the COVID-19 pandemic.

30 May 2022

New project investigates better ways to care for the psychological wellbeing of mothers

New mums can access free online self-care resources to help them cope with the challenges of motherhood, as part of an ongoing research trial by The University of Queensland.

30 May 2022

Discovery explains why patients with severe asthma are unresponsive to treatment

Patients with the most severe form of asthma produce special substances in their airways when taking medicine during an asthma attack that block the treatment from working, according to a study where Rutgers scientists collaborated with researchers at Genentech, a member of the Roche Group.

30 May 2022

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Millions of consumers and patients around the world will be heartened by the results of the latest study on cannabis and driving.

30 May 2022

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

The internationally renowned pharmaceutical scientist Professor Hans Lennernäs of Uppsala University has been given a Humboldt Research Award worth EUR 60,000 by the Alexander von Humboldt Foundation.

30 May 2022

New Director of Science, Research and Evidence will help steer research across health and social care

Dr Gail Marzetti has been appointed as the new Director of Science, Research and Evidence in the Department of Health and Social Care. She will take over the role previously held by Dr Louise Wood.

30 May 2022

Non-pharmaceutical help should be offered for pain, fatigue, anxiety at the time of MS diagnosis

Two recently published studies by UW Medicine researchers indicate that clinicians should offer non-pharmaceutical help for pain, fatigue, depression, or anxiety at the time of diagnosis for patients with multiple sclerosis, rather than wait.

30 May 2022

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Researchers assessed the neutralizing activity against SARS-CoV-2 Omicron variant after tixagevimab plus cilgavimab (T+C) administration.

30 May 2022

Study highlights clinical features and treatment approaches for human monkeypox in the UK

researchers from the UK unveil the details of imported, household, and hospital transmission of monkeypox and report the first usage of two specific antiviral agents in the treatment of this disease.

30 May 2022

Prevalence of SARS-CoV-2 infection during Omicron BA.2/BA.2.12.1 surge in New York

Researchers surveyed a representative sample of the adult population of New York City, United States, to determine the prevalence of COVID-19.

30 May 2022

Study investigates whether people with breakthrough SARS-CoV-2 infection develop post-acute sequelae

Researchers characterized long COVID-19 after a breakthrough COVID-19 infection.

30 May 2022

Novel photonic technology could enable fluorescent sensors to track molecules deep inside the body

Fluorescent sensors, which can be used to label and image a wide variety of molecules, offer a unique glimpse inside living cells.

30 May 2022

Sarbecovirus open reading frame 7a suppresses major histocompatibility complex-I antigen presentation

Researchers demonstrated the sarbecovirus open reading frame 7a (ORF7a)-induced hindrance of the antigen presentation by the major histocompatibility complex class I (MHC-I) in hosts.

30 May 2022

New approach to quantify cognitive decline in dogs could aid in the treatment of humans with Alzheimer’s

Researchers have found that a suite of complementary tests can quantify changes in dogs suspected of suffering from cognitive decline.

30 May 2022

Specially trained therapy dog expands the world for autistic children

A new Australian study looking at the impact of an autism assistance dog for children and their parents has made an unexpected discovery: the dog has expanded their world, literally.

30 May 2022

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Researchers identified 10-40, a human monoclonal antibody with potent neutralizing activity against SARS-CoV, SARS-CoV-2, and related sarbecoviruses.

30 May 2022

Medical News

COVID-19 lockdown restrictions impacted hospital admission rates throughout U.K.

Unsweetened and sugar-sweetened coffee drinkers may have lower risk of death

New compounds for cancer immunotherapy via STING-mediated immune activation

Vitamin D therapy may be a useful addition to the treatment of ovarian cancer, study suggests

Study reveals COVID-19's collateral damage on global cardiovascular services

New project investigates better ways to care for the psychological wellbeing of mothers

Discovery explains why patients with severe asthma are unresponsive to treatment

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

New Director of Science, Research and Evidence will help steer research across health and social care

Non-pharmaceutical help should be offered for pain, fatigue, anxiety at the time of MS diagnosis

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Study highlights clinical features and treatment approaches for human monkeypox in the UK

Prevalence of SARS-CoV-2 infection during Omicron BA.2/BA.2.12.1 surge in New York

Study investigates whether people with breakthrough SARS-CoV-2 infection develop post-acute sequelae

Novel photonic technology could enable fluorescent sensors to track molecules deep inside the body

Sarbecovirus open reading frame 7a suppresses major histocompatibility complex-I antigen presentation

New approach to quantify cognitive decline in dogs could aid in the treatment of humans with Alzheimer’s

Specially trained therapy dog expands the world for autistic children

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News